
Targeting O1a-Antigen for E. coli Vaccine Development
mai 12, 2025 2:31 pm Laissez vos commentaires🧬 Targeting O1a-Antigen for E. coli Vaccine Development 🧫 A May 2024 Pfizer Vaccine R&D study explores the development of... Read more
🧬 Targeting O1a-Antigen for E. coli Vaccine Development 🧫 A May 2024 Pfizer Vaccine R&D study explores the development of... Read more
This information was encountered near a lake in France two weeks ago: “Vigilance ponds and lakes: presence of cyanobacteria.” 😱... Read more
It seems that lipopolysaccharides (LPS) from Gram-negative bacteria can help analyze climate shifts. The lipid part of LPS is particularly... Read more
🌐LPS-BioSciences will be attending the Biopharma Innovation Summit hosted by Croda at Genopole on Thursday, November 14th, 2024! The goal... Read more
The use of Lipopolysaccharides (LPS) is on the rise in the cosmetics industry! 💄🧪 LPS-BioSciences will be at COSMETIC 360,... Read more
Did you know that air pollutants contain harmful lipopolysaccharides? 🦠 👉 According to the United Nations Agency, the most hazardous... Read more
We are pleased to welcome Nino Joasson, our new Research & Development intern at LPS-BioSciences!👨🔬 🧬 Nino is currently pursuing... Read more
At LPS-BioSciences, we use SDS-PAGE to profile lipopolysaccharides and endotoxins and analyze some of their structural properties. 🦠 👩🔬This electrophoresis technique,... Read more
Today, LPS-BioSciences had the pleasure of attending Medicen Day 2024, an exciting event hosted by Medicen Paris Region at the... Read more